Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Generic Drugs > U.S. Generic Pharmaceuticals Outlook
Category
Pharmaceutical (4989)
Bone Disease Treatment (46)
Cancer (883)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (406)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

U.S. Generic Pharmaceuticals Outlook

Published by Frost & Sullivan
Published April, 2007 Product code 51697
Content info 66 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


U.S. Generic Pharmaceuticals Outlook published by Frost & Sullivan in April, 2007. This report consists of 66 Pages and the price starts from US $ 6000.

Introduction

Abstract

This Frost & Sullivan research service titled U.S. Generic Pharmaceuticals Market Outlook provides a detailed analysis of this market, including competitive structure, market and revenue forecasts, and market share analysis. It also examines the major industry challenges and identifies the most promising opportunities for future market growth.

This research service is available through our Pharmaceuticals and Biotechnology Growth Partnership Service program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary
    • Executive Summary

2 U.S. GENERIC PHARMACEUTICALS MARKET

  • Market Overview
    • Introduction
    • Scope and Segmentation
    • Research Methodology
  • Market Dynamics
    • Market Engineering Measurements
    • Market Trends
    • Financial Snapshot
  • Market Forecasts
    • Prescription Forecasts
    • Revenue Forecasts
  • Competitive Landscape
    • Competitive Structure
    • Pipeline Analysis
    • Market Share Analysis
  • Challenges and Opportunities
    • Industry Challenges
    • Opportunities

3 DECISION SUPPORT DATABASES

  • Demographic Indicator
    • Total Population
  • Market Indicators
    • Government Healthcare Expenditure
    • Private Healthcare Expenditure
    • Pharmaceutical R&D Expenditure
    • Percent Pharmaceutical R&D Expenditure
    • Number of Hospitals
Back to Top